• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

灌注 CHO 细胞培养降低聚集并提高双特异性重组蛋白的体积产率。

Perfusion CHO cell culture applied to lower aggregation and increase volumetric productivity for a bispecific recombinant protein.

机构信息

Drug Substance Technologies, Amgen, Thousand Oaks, United States.

Drug Substance Technologies, Amgen, Thousand Oaks, United States.

出版信息

J Biotechnol. 2019 Oct 10;304:70-77. doi: 10.1016/j.jbiotec.2019.08.001. Epub 2019 Aug 2.

DOI:10.1016/j.jbiotec.2019.08.001
PMID:31381940
Abstract

Secreted recombinant proteins can aggregate during cell culture. We studied a poorly-behaved bispecific scaffold that increasingly aggregated (up to 62% high molecular weight species, HMW) as a function of culture time in a fed-batch and intensified cell culture processes. We identified that protein aggregates increased with accumulated protein concentration inside the bioreactor. Furthermore, results indicated that a maximum product concentration was reached beyond which no additional soluble protein accumulated in culture even when doubling the integrated viable cell density with the intensified process, suggesting additional secreted protein was precipitating. To overcome this limitation and maintain the cell-specific productivity (q) in culture, we explored a perfusion process where recombinant protein was continuously removed from the bioreactor to maintain low product concentration and consequently, minimize protein aggregation. We studied different viable cell densities (VCDs) inside the bioreactor (one to five-fold) and found a corresponding two-fold modulation of monomer levels. In all VCD conditions, q was maintained. On the contrary, the previous intensified process showed an "apparent" 2.5-fold decrease in q at the end of culture because of the presumed limited protein solubility at higher concentrations. The combination of lower aggregate levels and constant q resulted in up to four to five-fold increase in recoverable product (i.e., monomer) with the improved perfusion process.

摘要

分泌型重组蛋白在细胞培养过程中可能会发生聚集。我们研究了一种行为不良的双特异性支架,它在分批补料和强化细胞培养过程中随着培养时间的增加而逐渐聚集(高达 62%的高分子量物种,HMW)。我们发现,随着生物反应器内蛋白质浓度的积累,蛋白质聚集物增加。此外,结果表明,当集成的活细胞密度通过强化过程加倍时,产物浓度达到最大值,不再有额外的可溶性蛋白积累,表明额外的分泌蛋白沉淀。为了克服这一限制并保持培养过程中的细胞特异性产率(q),我们探索了一种灌注过程,其中重组蛋白连续从生物反应器中去除,以保持低产物浓度,从而最大限度地减少蛋白聚集。我们研究了生物反应器内不同的活细胞密度(VCD)(1 到 5 倍),发现单体水平相应地调节了两倍。在所有 VCD 条件下,q 得以维持。相反,之前的强化过程在培养结束时表现出“明显”的 q 值下降 2.5 倍,因为在较高浓度下假定蛋白质溶解度有限。较低的聚集水平和恒定的 q 值相结合,通过改进的灌注过程,使可回收产物(即单体)的产量增加了 4 到 5 倍。

相似文献

1
Perfusion CHO cell culture applied to lower aggregation and increase volumetric productivity for a bispecific recombinant protein.灌注 CHO 细胞培养降低聚集并提高双特异性重组蛋白的体积产率。
J Biotechnol. 2019 Oct 10;304:70-77. doi: 10.1016/j.jbiotec.2019.08.001. Epub 2019 Aug 2.
2
Bioreactor productivity and media cost comparison for different intensified cell culture processes.不同强化细胞培养工艺的生物反应器生产力与培养基成本比较
Biotechnol Prog. 2017 Jul;33(4):867-878. doi: 10.1002/btpr.2415. Epub 2017 Jan 28.
3
Improving product quality and productivity of bispecific molecules through the application of continuous perfusion principles.通过应用连续灌注原理提高双特异性分子的产品质量和生产力。
Biotechnol Prog. 2020 Jul;36(4):e2973. doi: 10.1002/btpr.2973. Epub 2020 Feb 13.
4
Perfusion reduces bispecific antibody aggregation via mitigating mitochondrial dysfunction-induced glutathione oxidation and ER stress in CHO cells.灌流通过减轻线粒体功能障碍诱导的谷胱甘肽氧化和 ER 应激来减少双特异性抗体聚集。
Sci Rep. 2020 Oct 6;10(1):16620. doi: 10.1038/s41598-020-73573-4.
5
Fed-batch performance profiles for mAb production using different intensified N - 1 seed strategies are CHO cell-line dependent.不同强化 N-1 种子策略对抗体生产的流加批次性能特征与 CHO 细胞系相关。
Biotechnol Prog. 2024 Jul-Aug;40(4):e3446. doi: 10.1002/btpr.3446. Epub 2024 Feb 28.
6
Process intensification in fed-batch production bioreactors using non-perfusion seed cultures.采用非灌注种培养物的流加生产生物反应器中的过程强化。
MAbs. 2019 Nov-Dec;11(8):1502-1514. doi: 10.1080/19420862.2019.1652075. Epub 2019 Aug 19.
7
Perfusion seed cultures improve biopharmaceutical fed-batch production capacity and product quality.灌注种子培养提高了生物制药补料分批培养的生产能力和产品质量。
Biotechnol Prog. 2014 May-Jun;30(3):616-25. doi: 10.1002/btpr.1884. Epub 2014 Mar 3.
8
Developing an ultra-intensified fed-batch cell culture process with greatly improved performance and productivity.开发一种超强化补料分批细胞培养工艺,具有显著提高的性能和生产力。
Biotechnol Bioeng. 2024 Feb;121(2):696-709. doi: 10.1002/bit.28605. Epub 2023 Nov 23.
9
Perfusion Cell Culture Decreases Process and Product Heterogeneity in a Head-to-Head Comparison With Fed-Batch.灌流细胞培养与分批培养的头对头比较降低了工艺和产品的异质性。
Biotechnol J. 2019 Feb;14(2):e1700733. doi: 10.1002/biot.201700733. Epub 2018 Jun 25.
10
Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.在不改变产品质量的情况下,将CHO细胞培养工艺从灌注技术转换为补料分批技术。
J Biotechnol. 2006 May 3;123(1):106-16. doi: 10.1016/j.jbiotec.2005.10.013. Epub 2005 Dec 1.

引用本文的文献

1
From Cell Clones to Recombinant Protein Product Heterogeneity in Chinese Hamster Ovary Cell Systems.从细胞克隆到中国仓鼠卵巢细胞系统中的重组蛋白产物异质性
Int J Mol Sci. 2025 Feb 4;26(3):1324. doi: 10.3390/ijms26031324.
2
Impact of fed-batch process intensification on the productivity and product quality of two CHO cell lines expressing unique novel molecular format proteins.补料分批培养过程强化对两种表达独特新型分子形式蛋白的中国仓鼠卵巢细胞系的生产力和产品质量的影响。
Bioprocess Biosyst Eng. 2024 Aug;47(8):1227-1240. doi: 10.1007/s00449-024-02997-3. Epub 2024 Apr 23.
3
WAVE-based intensified perfusion cell culture for fast process development.
基于波导的强化灌注细胞培养用于快速工艺开发。
Biotechnol Lett. 2023 Sep;45(9):1117-1131. doi: 10.1007/s10529-023-03405-8. Epub 2023 Jun 29.
4
Model predictive control for steady-state performance in integrated continuous bioprocesses.集成式连续生物过程中的稳态性能的模型预测控制。
Bioprocess Biosyst Eng. 2022 Sep;45(9):1499-1513. doi: 10.1007/s00449-022-02759-z. Epub 2022 Aug 2.
5
Engineering death resistance in CHO cells for improved perfusion culture.提高灌注培养中 CHO 细胞抗死亡能力的工程改造。
MAbs. 2022 Jan-Dec;14(1):2083465. doi: 10.1080/19420862.2022.2083465.
6
Productivity and quality improvement for a symmetric bispecific antibody through the application of intensified perfusion cell culture.通过强化灌注细胞培养提高对称双特异性抗体的生产力和质量
Antib Ther. 2022 May 3;5(2):111-120. doi: 10.1093/abt/tbac009. eCollection 2022 Apr.
7
Recombinant antibodies aggregation and overcoming strategies in CHO cells.CHO 细胞中重组抗体的聚集及其克服策略。
Appl Microbiol Biotechnol. 2022 Jun;106(11):3913-3922. doi: 10.1007/s00253-022-11977-0. Epub 2022 May 24.
8
Low Shear Stress Increases Recombinant Protein Production and High Shear Stress Increases Apoptosis in Human Cells.低剪切应力增加重组蛋白产量,高剪切应力增加人细胞凋亡。
iScience. 2020 Oct 7;23(11):101653. doi: 10.1016/j.isci.2020.101653. eCollection 2020 Nov 20.
9
Perfusion reduces bispecific antibody aggregation via mitigating mitochondrial dysfunction-induced glutathione oxidation and ER stress in CHO cells.灌流通过减轻线粒体功能障碍诱导的谷胱甘肽氧化和 ER 应激来减少双特异性抗体聚集。
Sci Rep. 2020 Oct 6;10(1):16620. doi: 10.1038/s41598-020-73573-4.